CATALOGO DEI PRODOTTI DELLA RICERCA

LUCHINI, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.088
EU - Europa 11.073
AS - Asia 9.019
SA - Sud America 1.692
AF - Africa 386
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 9
Totale 33.293
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.800
RU - Federazione Russa 4.720
SG - Singapore 3.690
CN - Cina 2.370
GB - Regno Unito 1.712
IT - Italia 1.515
BR - Brasile 1.336
HK - Hong Kong 973
VN - Vietnam 869
DE - Germania 613
IE - Irlanda 571
FR - Francia 537
SE - Svezia 471
FI - Finlandia 294
KR - Corea 293
IN - India 149
CA - Canada 139
NL - Olanda 133
AR - Argentina 132
JP - Giappone 118
UA - Ucraina 96
MX - Messico 95
BD - Bangladesh 82
TR - Turchia 77
NG - Nigeria 73
AT - Austria 69
ID - Indonesia 65
ES - Italia 64
ZA - Sudafrica 64
EC - Ecuador 62
BJ - Benin 60
PL - Polonia 57
TG - Togo 54
IQ - Iraq 53
BE - Belgio 38
VE - Venezuela 37
MA - Marocco 34
PK - Pakistan 31
CO - Colombia 29
PY - Paraguay 28
UZ - Uzbekistan 28
PH - Filippine 26
CL - Cile 25
CZ - Repubblica Ceca 22
KE - Kenya 21
AU - Australia 20
CH - Svizzera 20
SA - Arabia Saudita 20
MY - Malesia 19
PE - Perù 19
TN - Tunisia 19
HR - Croazia 16
AE - Emirati Arabi Uniti 14
JO - Giordania 14
AL - Albania 12
AZ - Azerbaigian 12
EG - Egitto 12
IR - Iran 12
LT - Lituania 12
LV - Lettonia 12
NP - Nepal 12
BO - Bolivia 11
KZ - Kazakistan 11
OM - Oman 11
DZ - Algeria 10
PT - Portogallo 10
SK - Slovacchia (Repubblica Slovacca) 10
UY - Uruguay 10
CR - Costa Rica 9
KG - Kirghizistan 9
RS - Serbia 9
IL - Israele 8
RO - Romania 8
BY - Bielorussia 7
LB - Libano 7
NO - Norvegia 7
PS - Palestinian Territory 7
SN - Senegal 7
CY - Cipro 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
JM - Giamaica 6
SI - Slovenia 6
HU - Ungheria 5
NI - Nicaragua 5
TH - Thailandia 5
AM - Armenia 4
AO - Angola 4
DK - Danimarca 4
EE - Estonia 4
GA - Gabon 4
MK - Macedonia 4
PA - Panama 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BB - Barbados 3
BH - Bahrain 3
CI - Costa d'Avorio 3
Totale 33.218
Salva come PNG Salva come JPEG
Città #
Singapore 1.834
Moscow 1.583
Ashburn 1.493
Dallas 1.391
Southend 1.351
San Jose 1.260
Chandler 1.045
Hong Kong 926
Verona 753
Dublin 543
The Dalles 481
Beijing 473
New York 321
Jacksonville 290
Ho Chi Minh City 284
Woodbridge 266
Los Angeles 217
Ann Arbor 203
Houston 187
Lawrence 181
Princeton 181
Munich 178
Hanoi 175
Wilmington 148
São Paulo 141
Council Bluffs 130
Helsinki 124
Redondo Beach 123
Buffalo 120
Jinan 118
Nanjing 111
London 103
Tokyo 100
Columbus 99
Santa Clara 99
Shenyang 91
Redmond 86
Sindelfingen 82
Milan 79
Abuja 71
Seattle 66
Orem 64
Hebei 61
Montreal 61
Cotonou 60
Tianjin 58
Turku 58
Guangzhou 55
Zhengzhou 55
Lomé 54
Amsterdam 51
Rio de Janeiro 51
Warsaw 50
Ningbo 49
Changsha 48
Da Nang 48
Redwood City 47
Nuremberg 46
Hangzhou 44
Rome 44
Seoul 44
Frankfurt am Main 43
Johannesburg 43
Stockholm 42
Taizhou 42
Vienna 40
Haikou 39
Brussels 38
Taiyuan 38
Chennai 37
Shanghai 37
Haiphong 36
Lancaster 35
Nanchang 35
Phoenix 34
San Francisco 34
Toronto 34
Chicago 33
Lappeenranta 33
Poplar 33
Denver 31
Paris 31
Belo Horizonte 30
Bologna 30
Atlanta 29
Brooklyn 29
Falkenstein 29
Jakarta 29
Jiaxing 28
Mexico City 28
Washington 28
Brasília 27
Madrid 24
Boston 23
Dong Ket 22
Boardman 21
Hải Dương 21
Tashkent 21
Barnet 20
Guayaquil 20
Totale 19.782
Salva come PNG Salva come JPEG
Nome #
Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis 294
Genomic characterization of hepatoid tumors: context matters 260
A rare case of three different tumors in the same pancreatic specimen: a case report and brief review of the literature 256
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 244
Tumor-like lesionsof the pancreas. 241
BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing 238
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers 225
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 215
CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas 213
Adherence to the Mediterranean diet is associated with better quality of life: data from the Osteoarthritis Initiative 212
Adenocarcinoma of the paraurethral glands: a case report 209
CD71 in Gestational Pathology: A Versatile Immunohistochemical Marker With New Possible Applications 202
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 197
Different Prognostic Roles Of Tumor Suppressor Gene BAP1 In Cancer: A Systematic Review With Meta-Analysis 196
Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysis 196
Ampulla of Vater carcinoma: Molecular landscape and clinical implications 196
Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis 194
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival 193
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 192
Artificial neural networks for multi-omics classifications of hepato-pancreato-biliary cancers: towards the clinical application of genetic data 192
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice? 192
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis 187
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 187
Epstein-Barr Virus-associated gastric cancer: a histopathologic study with comprehensive molecular profiling 186
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes 184
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 184
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 183
A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma 183
Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma 181
CD13 is a useful tool in the differential diagnosis of meningiomas with potential biological and prognostic implications 178
Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and Treatment 176
CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype 176
Epithelial-mesenchymal transition in undifferentiated carcinoma of the pancreas with and without osteoclast-like giant cells 175
Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance 175
Specific expression patterns of epithelial to mesenchymal transition factors in gestational molar disease 174
Fhit down-regulation is an early event in pancreatic carcinogenesis 174
Tracheobronchopathia Osteochondroplastica: A Case Report Illustrating the Importance of Multilevel Workup Clinical, Endoscopic and Histological Assessment in Diagnosis of an Uncommon Disease 172
Urachal carcinoma: from gross specimen to morphologic, immunohistochemical, and molecular analysis 171
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications 171
Pathological complete response in a patient affected by multiple synchronous, breast and lung primary malignancies: a case report and review of the literature 168
Adherence to a Mediterranean diet is associated with lower prevalence of osteoarthritis: Data from the osteoarthritis initiative 167
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 167
Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis 167
Sex differences in oncogenic mutational processes 166
Extranodal extension in N1-adenocarcinoma of the pancreas and papilla of Vater: a systematic review and meta-analysis of its prognostic significance 165
Ampullary Neuroendocrine Neoplasms: Identification of Prognostic Factors in a Multicentric Series of 119 Cases 165
Loss of FGFR4 promotes the malignant phenotype of PDAC 164
Exosomal miRNA signatures of pancreatic lesions 160
High-risk Pancreatic Anastomosis vs. Total Pancreatectomy after Pancreatoduodenectomy: Postoperative Outcomes and Quality of Life Analysis 160
Hepatoid tumors of the gastrointestinal/pancreatobiliary district: morphology, immunohistochemistry, and molecular profiles 158
Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis 158
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 158
Next-Generation Histopathologic Diagnosis: A Lesson From a Hepatic Carcinosarcoma 157
Extranodal extension is an important prognostic parameter for both colonic and rectal cancer 157
ASO Visual Abstract: Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective Lymphadenectomy Protocol 157
Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation 156
Cell of origin markers identify different prognostic subgroups of lung adenocarcinoma 156
Platinum-Based Treatment for Well- and Poorly Differentiated Pancreatic Neuroendocrine Neoplasms 156
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma 156
Endoscopic ultrasound fine-needle biopsy to assess DAXX/ATRX expression and alternative lengthening of telomeres status in non-functional pancreatic neuroendocrine tumors 155
From Genetic Alterations to Tumor Microenvironment: The Ariadne's String in Pancreatic Cancer 153
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions 153
Either High or low Risk: The Acinar Score at the Resection Margin Dichotomizes the Risk Spectrum Of Pancreas-specific Complications After Pancreatoduodenectomy 152
Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis 152
Metastatic malignant melanoma to the gallbladder. Case report and review of the literature 151
KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities 151
Efficacy and Toxicity Analysis of mFOLFIRINOX in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms 150
Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases 150
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas 149
Amsterdam International Consensus Meeting: tumor response scoring in the pathology assessment of resected pancreatic cancer after neoadjuvant therapy 149
Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variants 149
Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection 148
Serous Neoplasms 148
Acetylcholinesterase inhibitors and memantine in bipolar disorder: A systematic review and best evidence synthesis of the efficacy and safety for multiple disease dimensions 147
CARATTERISTICHE CLINICO-PATOLOGICHE, PROFILO MOLECOLARE E BERSAGLI PER L’IMMUNOTERAPIA NEI CARCINOMI INDIFFERENZIATI DEL PANCREAS CON CELLULE GIGANTI SIMIL-OSTEOCLASTICHE 147
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 147
Malignant epithelial/exocrine tumors of the pancreas 147
Histo-molecular characterization of pancreatic cancer with microsatellite instability: intra-tumor heterogeneity, B2M inactivation, and the importance of metastatic sites 147
ARID1A mutational status in non-small cell lung cancer: from molecular pathology to clinical implications with a focus on the relationships with EGFR 146
Inflammatory and tumor-like lesions of the pancreas 146
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumours display divergent genomic and transcriptomic profiles 146
Circulating tumour DNA: a challenging innovation to develop "precision onco-surgery" in pancreatic adenocarcinoma 146
Long-term organoid culture of a small intestinal neuroendocrine tumor 145
CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 145
Artificial intelligence in oncology: current applications and future perspectives 144
Artificial Intelligence for Predicting Microsatellite Instability Based on Tumor Histomorphology: A Systematic Review 144
ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach 143
Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primary 141
Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma 141
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association 141
Evaluating Mismatch Repair Deficiency for Solid Tumor Immunotherapy Eligibility: Immunohistochemistry versus Microsatellite Molecular Testing 139
Endoscopic ultrasound guided fine needle biopsy samples to drive personalized medicine: A proof of concept study 137
ASO Visual Abstract: Ca 19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 136
Solid pseudopapillary tumors of the pancreas: Specific pathological features predict the likelihood of postoperative recurrence 136
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial 135
Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas 135
Intraductal Papillary Mucinous Neoplasm (IPMN) 133
Forensic value of soft tissue detachments from the hyoid bone in death due to strangulation asphyxia 132
An Insight on Functioning Pancreatic Neuroendocrine Neoplasms 131
Surgery for pancreatic neuroendocrine tumors during the COVID-19 pandemic: a retrospective cohort from a high-volume center 131
Totale 16.910
Salva come PNG Salva come JPEG
Categoria #
all - tutte 116.997
article - articoli 112.846
book - libri 0
conference - conferenze 608
curatela - curatele 0
other - altro 395
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.148
Totale 233.994
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021205 0 0 0 0 0 0 0 0 0 35 104 66
2021/20221.468 108 378 66 123 35 36 43 129 68 39 95 348
2022/20233.134 206 333 284 520 250 777 51 205 352 40 74 42
2023/20242.166 92 166 161 222 233 318 198 152 40 96 369 119
2024/20256.034 324 282 259 912 301 211 377 317 867 466 564 1.154
2025/202617.082 1.234 997 1.634 2.785 4.249 1.043 1.509 1.110 1.560 961 0 0
Totale 34.021